JP2014524475A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524475A5
JP2014524475A5 JP2014527282A JP2014527282A JP2014524475A5 JP 2014524475 A5 JP2014524475 A5 JP 2014524475A5 JP 2014527282 A JP2014527282 A JP 2014527282A JP 2014527282 A JP2014527282 A JP 2014527282A JP 2014524475 A5 JP2014524475 A5 JP 2014524475A5
Authority
JP
Japan
Prior art keywords
amino
pyridazin
phenyl
oxo
dihydropyrimido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014527282A
Other languages
English (en)
Japanese (ja)
Other versions
JP5993010B2 (ja
JP2014524475A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/051980 external-priority patent/WO2013028818A1/en
Publication of JP2014524475A publication Critical patent/JP2014524475A/ja
Publication of JP2014524475A5 publication Critical patent/JP2014524475A5/ja
Application granted granted Critical
Publication of JP5993010B2 publication Critical patent/JP5993010B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014527282A 2011-08-23 2012-08-23 ピリミド−ピリダジノン化合物及びその使用 Active JP5993010B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161526525P 2011-08-23 2011-08-23
US61/526,525 2011-08-23
PCT/US2012/051980 WO2013028818A1 (en) 2011-08-23 2012-08-23 Pyrimido- pyridazinone compounds and use thereof

Publications (3)

Publication Number Publication Date
JP2014524475A JP2014524475A (ja) 2014-09-22
JP2014524475A5 true JP2014524475A5 (enExample) 2015-10-15
JP5993010B2 JP5993010B2 (ja) 2016-09-14

Family

ID=46829884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014527282A Active JP5993010B2 (ja) 2011-08-23 2012-08-23 ピリミド−ピリダジノン化合物及びその使用

Country Status (14)

Country Link
US (5) US8729079B2 (enExample)
EP (4) EP4327886A3 (enExample)
JP (1) JP5993010B2 (enExample)
CN (2) CN108707151B (enExample)
BR (1) BR112014003981A2 (enExample)
CA (1) CA2846187A1 (enExample)
DK (2) DK2748166T3 (enExample)
ES (2) ES2690971T3 (enExample)
FI (1) FI3392252T3 (enExample)
HU (1) HUE065564T2 (enExample)
IL (1) IL231082A (enExample)
MX (1) MX361458B (enExample)
PL (1) PL2748166T3 (enExample)
WO (1) WO2013028818A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX361458B (es) * 2011-08-23 2018-12-06 Asana Biosciences Llc Compuestos de pirimido-piridazinona y uso de los mismos.
AR106830A1 (es) * 2015-12-04 2018-02-21 Asana Biosciences Llc Usos de piridazinonas para tratar el cáncer
WO2018187294A1 (en) * 2017-04-03 2018-10-11 Asana Biosciences, Llc Pyrimido-pyridazinone compound combinations, methods, kits and formulations thereof
WO2018201131A1 (en) 2017-04-28 2018-11-01 Asana Biosciences, Llc Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredient
CN111961035B (zh) * 2019-05-20 2022-11-01 南京科技职业学院 一类含有羟基异喹啉类结构的化合物、药物组合物以及其应用
WO2021027943A1 (zh) * 2019-08-14 2021-02-18 正大天晴药业集团南京顺欣制药有限公司 哒嗪酮并嘧啶类衍生物及其医药用途
CN113583026B (zh) * 2020-04-30 2024-06-14 杭州英创医药科技有限公司 一类含有稠合三环结构的化合物
WO2022002118A1 (zh) * 2020-07-01 2022-01-06 四川海思科制药有限公司 一种并环杂环衍生物及其在医药上的应用
WO2023122662A1 (en) * 2021-12-22 2023-06-29 The Regents Of The University Of California Covalently binding inhibitors of g12s, g12d and/or g12e mutants of k-ras gtpase
CA3244694A1 (en) * 2022-02-23 2023-08-31 Assia Chemical Industries Ltd. SOLID FORMS OF GUSACITINIB
WO2023192989A2 (en) * 2022-04-01 2023-10-05 Azkarra Therapeutics, Inc. Phthalazinone compounds as parp7 inhibitors
WO2025024765A1 (en) 2023-07-27 2025-01-30 Libertas Bio, Inc. Solid state forms of gusacitinib
WO2025020171A1 (en) * 2023-07-27 2025-01-30 Libertas Bio, Inc. Crystalline forms of a jak/syk inhibitor

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756508A (fr) * 1969-09-24 1971-03-01 Takeda Chemical Industries Ltd Derives de pyrimidopyridazine
CA1004223A (en) * 1972-05-12 1977-01-25 Theodor Denzel Amino derivatives of pyrido(2,3-d)pyridazine carboxylic acids and esters
JPS4948695U (enExample) 1972-07-29 1974-04-27
JPS50101387A (enExample) * 1974-01-16 1975-08-11
CA1052046A (en) 1974-01-21 1979-04-03 American Cyanamid Company Unsymmetrically substituted 1,4-dioxane-2,5-diones
US5369086A (en) 1993-04-28 1994-11-29 Zeneca Limited N-benzotriazoles
IL112249A (en) 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
JPH0948695A (ja) 1995-08-02 1997-02-18 Toshiba Ceramics Co Ltd シリコン単結晶の製造方法
WO1999043671A1 (en) 1998-02-25 1999-09-02 Pharmacia & Upjohn Company Substituted aminomethyl isoxazoline derivatives useful as antimicrobials
KR100658489B1 (ko) 1998-11-10 2006-12-18 얀센 파마슈티카 엔.브이. Hiv 복제를 억제하는 피리미딘
CA2422054C (en) * 2000-09-22 2011-01-11 Akzo Nobel Nv Bicyclic heteroaromatic compounds
JP2004528349A (ja) 2001-04-30 2004-09-16 グラクソ グループ リミテッド 副腎皮質刺激ホルモン放出因子(crf)のアンタゴニストとしての縮合ピリミジン類
AU2003212634A1 (en) 2002-03-11 2003-09-22 Zetiq Technologies Ltd. Compounds useful in the treatment of cancer
MXPA05001096A (es) 2002-07-29 2005-11-23 Rigel Pharmaceuticals Inc Metodos para tratamiento o prevencion de enfermedades autoinmunes con compuestos de 2,4-diamino-pirimidina.
US7550590B2 (en) 2003-03-25 2009-06-23 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
AU2004265288A1 (en) 2003-07-30 2005-02-24 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
TW200538120A (en) 2004-02-20 2005-12-01 Kirin Brewery Compound having TGF-beta inhibitory activity and pharmaceutical composition containing same
RU2405778C2 (ru) 2004-09-30 2010-12-10 Тиботек Фармасьютикалз Лтд. 5-гетероциклилпиримидины, ингибирующие вич
US7795275B2 (en) 2004-12-24 2010-09-14 Uniquest Pty Limited Method of treatment or prophylaxis
JP2008534479A (ja) 2005-03-25 2008-08-28 テイボテク・フアーマシユーチカルズ・リミテツド Hcvの複素二環式阻害剤
WO2006105063A1 (en) 2005-03-25 2006-10-05 Scios Inc. Heterobicylic inhibitors of tgfbeta
DE602006007832D1 (de) 2005-04-29 2009-08-27 Janssen Pharmaceutica Nv Benzotriazolderivate als cannabinoidrezeptorantagonisten
EP1970373A1 (en) * 2005-12-02 2008-09-17 Mitsubishi Tanabe Pharma Corporation Alicyclic heterocyclic compound
US20070161670A1 (en) 2006-01-09 2007-07-12 Bristol-Myers Squibb Company Process for the preparation of substituted heterocycles
JP2009535393A (ja) 2006-05-01 2009-10-01 ファイザー・プロダクツ・インク 置換2−アミノ縮合複素環式化合物
GB0625196D0 (en) 2006-12-18 2007-01-24 7Tm Pharma As Modulators of cannabinoid receptor
CN103690542B (zh) * 2006-12-28 2015-11-18 Abbvie公司 聚(adp-核糖)聚合酶抑制剂
GEP20135925B (en) 2007-03-14 2013-10-10 Exelixis Patent Co Llc Inhibitors of hedgehog pathway
TW200942537A (en) 2008-02-01 2009-10-16 Irm Llc Compounds and compositions as kinase inhibitors
MX2011003447A (es) * 2008-09-30 2011-07-29 Astrazeneca Ab Inhibidores heterociclicos de jak quinasa.
AR073760A1 (es) 2008-10-03 2010-12-01 Astrazeneca Ab Derivados heterociclicos y metodos de uso de los mismos
AR073949A1 (es) 2008-10-21 2010-12-15 Metabolex Inc Agonistas del receptor aril-gpr120 y usos de los mismos
MX2012004846A (es) * 2009-10-29 2012-10-05 Genosco Inhibidores de cinasa.
TW201130852A (en) * 2009-12-23 2011-09-16 Abbott Lab Novel thienopyrrole compounds
WO2012058671A1 (en) 2010-10-31 2012-05-03 Endo Pharmaceuticals Inc. Substituted quinazoline and pyrido-pyrimidine derivatives
MX361458B (es) * 2011-08-23 2018-12-06 Asana Biosciences Llc Compuestos de pirimido-piridazinona y uso de los mismos.
WO2014022728A1 (en) 2012-08-02 2014-02-06 Endo Pharmaceuticals, Inc Substituted 5 - (quinazolin - 2 - yl) pyrimidin- 2 -amine derivatives useful as pi3k/mtor inhibitors for the treatment of cancer
AR106830A1 (es) * 2015-12-04 2018-02-21 Asana Biosciences Llc Usos de piridazinonas para tratar el cáncer
WO2018201131A1 (en) * 2017-04-28 2018-11-01 Asana Biosciences, Llc Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredient

Similar Documents

Publication Publication Date Title
JP2014524475A5 (enExample)
ES2922174T3 (es) Compuestos de indol sustituidos con amida útiles como inhibidores de TLR
JP2019517596A5 (enExample)
AU2016352813B2 (en) Novel pyrazolo pyrimidine derivatives
AU2013210438B2 (en) Pyrazine carboxamide compound
RU2018124289A (ru) Применения пиримидо-пиридазинонов для лечения рака
ES2946274T3 (es) Inhibidores de TRPC6
JP7366994B2 (ja) 自己免疫疾患治療用の新規ピペラジン化合物
KR20230024251A (ko) 신규 plk1 분해 유도 화합물
AU2015304883A1 (en) Aminopyrimidinyl compounds as JAK inhibitors
RU2014154397A (ru) Соединения тетрагидропиразолопиримидина
EP2925322A1 (en) Inhibitors of the renal outer medullary potassium channel
CN116490184A (zh) 用于抑制egfr突变癌症的化合物及其药物用途
KR20140138851A (ko) 류코트리엔 생성 억제를 위해 기타 활성제와 병용된 벤조디옥산
KR20150127721A (ko) 디하이드로피리다진-3,5-디온 유도체
KR102646850B1 (ko) 안드로겐 수용체 분해용 화합물 및 이들의 의약 용도
WO2024059808A1 (en) Wee1 inhibitors and methods for treating cancer
RU2666894C2 (ru) Производные пиперидинмочевины
JP2024009891A (ja) T型カルシウムチャネル阻害剤
RU2472781C2 (ru) Новые соединения 707 и их применение
RU2006146621A (ru) Производные нафталина, пригодные в качестве лигандов рецепторов 3 гистамина
KR20230159524A (ko) Bcl-2 저해제로서 ((3-나이트로페닐)설포닐)아세트아마이드를 갖는 화합물
WO2024222726A1 (zh) 细胞周期蛋白依赖性激酶12/13的降解剂、组合物及其应用
JP2022081710A (ja) 関節リウマチを治療するためのt型カルシウムチャネル阻害剤の使用
AU2023330130A1 (en) Compounds and methods for modulating her2